But in HCC patients, serum miR-122 increased significantly and the serum miR-122 had better diagnostic capacity than AFP and GPC3 in distinguishing early-stage HCC from high-risk LC patients. The gene discussed is AFP; the disease is laryngotracheoesophageal cleft.